Trial intelligence / Profile preview

ROAD: Response to Oral Agents in Diabetes Pilot Study

NCT00780715Phase 4Completed

Sponsor
University of Dundee
Start
Dec 2008
Primary completion
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of metformin, gliclazide, sitagliptin, pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by University of Dundee. Started Dec 2008; status: completed.

02

Drugs

metformingliclazidesitagliptinpioglitazone
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00780715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00780715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call